Headache in a group of SARS-COVID-19 patients: an observational prospectical study.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. What can the neurological manifestations of COVID-19 tell us: a meta-analysis.Journal of translational medicine · 2021
   Pooled it
2. Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients.Frontiers in neurology · 2020
   Pooled it
3. COVID-19 lockdown attack on headache emergency admissions: a multidisciplinary retrospective study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
   Article

Corrections and comments

• Comment on
  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.2020

Authors and funding

17 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as